Weil Gotshal Advises Lilly In $800M Avid Deal
Eli Lilly & Co. said Monday it had agreed to buy privately held molecular imaging developer Avid Radiopharmaceuticals Inc. for $300 million up front and a possible $500 million milestone payment...To view the full article, register now.
Already a subscriber? Click here to view full article